Effect of pretreatment with prostaglandin F2alpha before resynchronization of ovulation on fertility of lactating dairy cows.
Our objective was to assess the effect of pretreatment with PGF(2alpha) 12 d before initiation of a protocol for resynchronization of ovulation (Resynch) using an Ovsynch protocol. Lactating Holstein cows diagnosed not pregnant 31 d after a timed artificial insemination (TAI) were randomly assigned to initiate the Resynch protocol 32 d after TAI (n = 255; RES), or receive 25 mg of PGF(2alpha) 34 d after TAI and initiate the Resynch protocol 12 d later at 46 d after TAI (n = 272; PGF+RES). Within each treatment, a subset of cows were examined using transrectal ultrasonography to determine ovulatory response to the first GnRH injection of the Resynch protocols or a blood sample was collected to determine serum progesterone (P(4)) at initiation of the Resynch protocol, or both. Overall, PGF+RES cows had more pregnancies per artificial insemination (P/AI) than RES cows 66 d after TAI (35.2 vs. 25.6%), whereas pregnancy loss from 31 to 66 d after TAI was greater for RES than PGF+RES cows (17.1 vs. 7.6%). Although P/AI was greater for cows with high (>/=1.0 ng/mL) vs. low (<1.0 ng/mL) P(4) at the first GnRH injection of the Resynch protocols, treatment did not affect the proportion of cows with low P(4) at the first GnRH injection of the Resynch protocols. Overall, no effect of treatment on ovulatory response to the first GnRH injection of the Resynch protocols was detected. We conclude that pretreatment with PGF(2alpha) 12 d before initiation of the Resynch protocol increased P/AI 66 d after TAI for cows with serum P(4) concentration >1.0 ng/mL at the first GnRH injection of the Resynch protocol and decreased pregnancy loss from 31 to 66 d after TAI. This modified resynchronization protocol may be a useful strategy for reproductive management of lactating dairy cows.
Silva
E
E
Department of Dairy Science, University of Wisconsin, Madison 53706, USA.
Sterry
R A
RA
Kolb
D
D
Wiltbank
M C
MC
Fricke
P M
PM
D000034:Abortion, Veterinary / Q000453:epidemiology; D000818:Animals; D002417:Cattle / Q000502:physiology*; D015237:Dinoprost / Q000494:pharmacology*; D005260:Female; D005298:Fertility / Q000187:drug effects* / Q000502:physiology; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007315:Insemination, Artificial / Q000662:veterinary; D007774:Lactation / Q000502:physiology; D010060:Ovulation / Q000187:drug effects* / Q000502:physiology; D010062:Ovulation Induction / Q000379:methods / Q000662:veterinary*; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000662:veterinary; D018873:Pregnancy Rate; D011374:Progesterone / Q000097:blood; D011897:Random Allocation; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D015237:Dinoprost